Sat. Oct 3rd, 2026

New York, USA / Timesnewswire / October 3, 2026 – On October 1, Beijing Time, New York’s Times Square, known as the “crossroads of the world,” was bustling with pedestrians and traffic. One of the most dazzling landmarks in Times Square, the Nasdaq digital billboard, featured a series of visuals centered on SPF Rongchang pigs, instantly capturing the attention of numerous passersby.

(Location: Times Square, New York)

Against a vibrant festive “Chinese red” background, three adorable Rongchang pigs poked their heads into view on the giant poster: their rosy faces, bright black eyes, and distinctive “panda eyes” around the eyes created a charming contrast with the golden fireworks blooming in the background. The Chinese slogan “The world looks to China for collagen, and China’s collagen comes from Rongchang” and the English tagline “CHINA · RONGCHANG—A NEW SOURCE OF COLLAGEN” stood out prominently.

The “panda pigs” of Rongchang appearing alongside iconic landmarks created a striking visual fusion of cuteness and contemporary style. Passersby were drawn to this charming and confident presence from the East, some stopping to gaze, while others raised their phones to capture the rare moment.

In addition to New York’s Times Square, SPF Rongchang pigs also made appearances at Leicester Square in London, the Eiffel Tower in Paris, Causeway Bay in Hong Kong, and Baima Hang in Macao. This spectacular global campaign was not only an impressive showcase of China’s biotechnology, but also an industry statement transcending borders—the powerful declaration that “the world looks to China for collagen, and China’s collagen comes from Rongchang” has demonstrated China’s industrial strength in technological innovation to the world, further enhancing the global recognition and influence of SPF Rongchang pigs in the field of biomaterials.

(Location: Leicester Square, London)

(Location: Eiffel Tower, Paris)

(Location: Causeway Bay, Hong Kong)

(Location: Baima Hang, Macao)

It is understood that in June this year, the collagen implant “Jiaoyuan Shaonv® COLLARRIA®,” developed by Chongqing Fanghe Biotechnology Co., Ltd., obtained the Class III Medical Device Registration Certificate from the National Medical Products Administration (NMPA), with Registration Certificate No. “Guoxie Zhuzhun 20263131252.” The product consists of Type I collagen purified from the skin of SPF Rongchang pigs.

From overcoming the two core technologies of sterile cesarean delivery and sterile breeding to establishing a fully integrated chain covering “breeding—purification—farming—medical biomaterial production,” every step toward independent control has been hard-won. This breakthrough was destined to face multiple challenges, requiring not only the courage to venture and innovate, but also the perseverance to pursue a long-term goal with unwavering determination. By securing control over key links such as genetic resources, technology, and standards, and by promoting collaboration across the industry alliance and the commercialization of research achievements, China can firmly take the initiative in its own hands in the field of high-end biomaterials.

From the breeding bases in Rongchang, Chongqing, to the “crossroads of the world,” these “panda pigs” are carrying the calling card of “China Collagen” and steadily making their own mark on the international stage.